Our results demonstrate that NRF2 pathway-mutated NSCLC represents a smoking-associated, high-risk molecular subtype frequently accompanied by detrimental SMARCA4 mutations. The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.